https://www.selleckchem.com/pr....oducts/ginkgolic-aci
I are low. Age, baseline ALT, haemoglobin and HBsAg positivity are risk factors for the development of DILI and these inform monitoring and management of these patients. The efficacy and safety of a fluid-filled intragastric balloon (IG for weight loss in cirrhotic patients on the liver-transplant waitlist is unknown. We enrolled stable compensated waitlisted patients with BMI 35 for IGB placement endoscopically for a maximum of 6 months. 8 patients (7 male), 56 ± 4.6 years with MELDNa 14.1 ± 3.4 experienced weight re
Like
Comment
Share
